We just did this share analysis in our post grad class with my professor and this share seems to be very undervalued floating around $15-16 price mark. Solid company, good management, just the market is working up and no one has cash to invest. In concluding, best price to get in at the moment before it goes back up. I currently just bought at 15.690, which seems like a very good price to get in seeing how a solid company like this will go back up.
- Forums
- ASX - By Stock
- QBE
- so...who is buying?
so...who is buying?, page-4
Featured News
Add QBE (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.30 |
Change
-0.010(0.05%) |
Mkt cap ! $29.04B |
Open | High | Low | Value | Volume |
$19.30 | $19.35 | $19.16 | $21.98M | 1.140M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 2417 | $19.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.31 | 1523 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 466 | 19.270 |
26 | 2477 | 19.260 |
19 | 4070 | 19.250 |
11 | 2772 | 19.240 |
11 | 4953 | 19.230 |
Price($) | Vol. | No. |
---|---|---|
19.280 | 1143 | 12 |
19.290 | 4977 | 25 |
19.300 | 2573 | 14 |
19.310 | 2136 | 11 |
19.320 | 6825 | 11 |
Last trade - 15.30pm 18/11/2024 (20 minute delay) ? |
Featured News
QBE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online